Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases

Familial Cancer

Volumn 11, Issue 3, 2012, Pages 351-354

  Brozek, Izabela ^a   Ratajska, Magdalena ^a   Piatkowska, Magdalena ^b   Kluska, Anna ^b   Balabas, Aneta ^b   Dabrowska, Michalina ^b   Nowakowska, Dorota ^b   Niwinska, Anna ^b   Rachtan, Jadwiga ^c   Steffen, Jan ^b   Limon, Janusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

BRCA1 mutation; Family history; Hereditary breast cancer; Hereditary ovarian cancer

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POLAND; PRIORITY JOURNAL;

BRCA1 PROTEIN; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC TESTING; HUMANS; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; POLAND;

EID: 84870443363     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-012-9519-5     Document Type: Article

References (23)

1. Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, hispanic and other minority families in the United States. J Clin Oncol 27(8):1184-1190
2. King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risk due to inherited mutation in BRCA1 and BRCA2. Science 302(5645):643-646
3. Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario. Can J Natl Cancer Inst 98(23):1694-1706
4. Metcalfe KA, Poll A, Royer R et al (2010) Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 28(3):387-391
5. Brozek I, Cybulska C, Ratajska M et al (2011) Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet 52(3):325-330
6. Jasinska A, Krzyzosiak WJ (2001) Prevalence of BRCA1 founder mutations in western Poland. Hum Mutat 17(1):75
7. Gorski B, Byrski T, Huzarski T et al (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66(6):1963-1968
8. Ratajska M, Brozek I, Senkus-Konefka E et al (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19(1):263-268
9. Perkowska M, Brozek I, Wysocka B et al (2003) BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from north-eastern Poland. Hum Mutat 21(5):553-554
10. Van Der Looij M, Wysocka B, Brozek I et al (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15:480-487
11. Grzybowska E, Zientek H, Jasinska A et al (2000) High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16(6):482-490
12. Janiszewska H, Haus O, Lauda-Swieciak A et al (2003) Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland. Clin Genet 64(6):502-508
13. Whittemore AS, Gong G, John EM et al (2004) Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev 13(12):2078-2083
14. Gorski B, Cybulski C, Huzarski T et al (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92(1):19-24
15. Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a populationbased study of breast cancer in white and black American women, ages 35 to 64 years. Cancer Res 66(16):8297-8308
16. Sokolenko AP, Mitiushkina NV, Buslov KG et al (2006) High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer 42(10):1380-1384
17. John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298(24):2869-2876
18. John EM (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22(1):72-78
19. Weitzel JN, Lagos VI, Cullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297(23):2587-2595
20. Atchley DP, Albarracin CT, Lopez A et al (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26(26):4282-4288
21. James PA, Doherty R, Harris M et al (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24(4):707-715
22. Vargas AC, Silva LD, Lakhani SR (2010) The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers. Fam Cancer 9(4):545-553
23. Brozek I, Ochman K, Debniak J et al (2008) High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland. Gynecol Oncol 108(2):433-437